medigraphic.com
ISSN 2448-8909 (Print)

2016, Number 3

<< Back Next >>

Med Crit 2016; 30 (3)

The year in septic shock

Rodríguez RMR, Quiñonez MA, Martínez SRA

Language: Spanish
References: 23
Page: 198-203
PDF size: 161.79 Kb.


ABSTRACT

Septic shock represents the most common type of circulatory shock and likewise the most common cause of death in the Intensive Care Unit. Considering the advances made in evidence based medicine, we decide to illustrate the reader with a selection of articles that can possibly change our clinical practice regarding septic shock, that were published in the years 2013 and 2014. Current guidelines emphasize certain changes, like the preference of cristaloids over coloids for resuscitation fluids, the designation of norepinephrine as the vasopressor of choice and the emphasize they put on protocol based care. Despite of that, recent publications have shifted pur paradigm of protocol based care and as to which crystalloid solution is the best for the management of this patients. It can be concluded that the most important aspects for the management of septic shock regarding a decrease in mortality are the early recognition of the sepsis syndrome, early initiation (within the first hour) of antibiotics and prompt administration of resuscitation fluids.


REFERENCES

  1. Angus D, van der Pohl T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-851.

  2. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726-1734.

  3. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308-1316.

  4. Linder A, Guh D, Boyd J, Walley K, Anis A, Russell J. Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med. 2014;42:2211-2218.

  5. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal S, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013;41:580-637.

  6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.

  7. ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-1693.

  8. ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-1506.

  9. Ferrer C, Loeches I, Phillips G, Osborn T, Townsend S, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749-1755.

  10. Rochwerg B, Alhazzani W, Sindi A, Ansdell D, Thabane L, Robichoud A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161:347-355.

  11. Kadri SS, Danner RL. ACP Journal Club: review: in sepsis, the effect of resuscitation with crystalloid and colloid fluids on mortality varies. Ann Intern Med. 2014;161(10):JC12.

  12. Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan M, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585-1591.

  13. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243-1251.

  14. Waechter J, Kumar A, Lapinsky S, Marshall J, Dodek P, Arabi Y, et al. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med. 2014;42:2158-2168.

  15. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317(11):653-658.

  16. Kox M, Pickkers P. “Less is more” in critically ill patients: not too intensive. JAMA Intern Med. 2013;173(14):1369-1372.

  17. Funk D, Doucette S, Pisipati A, Dodek P, Marshall JC, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Low-dose corticosteroid treatment in septic shock: a propensity-matching study. Crit Care Med. 2014;42(11):2333-2341.

  18. Trzeciak S, Glaspey LJ, Dellinger RP, Durflinger P, Anderson K, Dezfulian C, et al. Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis. Crit Care Med. 2014;42(12):2482-2492.

  19. Janz DR, Bastarache JA, Rice TW, Bernard GR, Warren MA, Wickersham N, et al. Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial. Crit Care Med. 2015;43(3):534-541.

  20. TRISS Trial Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381-191.

  21. ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412-1421.

  22. SEPSISPAM Investigators. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583-9153.

  23. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683-1691.




2020     |     www.medigraphic.com